Eve Baldrich
Family Medicine · Milford, DENPI 1831288224
Payments from drug & device makers
Across 121 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$565
- Boehringer Ingelheim$369
- Lilly USA, LLC$264
- Pfizer$201
- AstraZeneca$196
- GSK$193
- plus $638 from 16 others
What the payments were for
- Food & beverage$2,426100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 23 | $565 |
| Boehringer Ingelheim | 10 | $369 |
| Lilly USA, LLC | 18 | $264 |
| Pfizer | 11 | $201 |
| AstraZeneca | 11 | $196 |
| GSK | 10 | $193 |
| Astellas Pharma US Inc | 7 | $113 |
| Dexcom, Inc. | 4 | $67 |
| Exact Sciences | 4 | $60 |
| Sanofi Pasteur Inc. | 3 | $59 |
| Kowa Pharmaceuticals America, Inc. | 3 | $58 |
| Merck | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| AbbVie | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Amgen | 2 | $27 |
| Eisai Inc. | 1 | $23 |
| Abbott | 1 | $23 |
| Novartis | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,426 in reported general payments places this provider in the 80th percentile of 352 family medicine providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 92 | $136,813 |
| EliquisApixaban | 43 | $68,347 |
| OzempicSemaglutide | 31 | $65,739 |
| TrulicityDulaglutide | 28 | $64,180 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 21 | $37,126 |
| JanuviaSitagliptin Phosphate | 30 | $34,459 |
| RybelsusSemaglutide | 13 | $31,098 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $30,174 |
| JanumetSitagliptin Phos/Metformin Hcl | 13 | $21,193 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 37 | $14,035 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $9,775 |
| Rosuvastatin Calcium | 308 | $8,241 |
| Admelog SolostarInsulin Lispro | 11 | $7,668 |
| Atorvastatin Calcium | 370 | $6,017 |
| Levothyroxine Sodium | 417 | $5,773 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $369 | $136,81392 claims |
| Novo NordiskOzempic, Rybelsus | $565 | $96,83644 claims |
| PfizerEliquis | $201 | $68,34743 claims |
| Lilly USA, LLCTrulicity | $264 | $64,18028 claims |
| MerckJanuvia, Janumet | $45 | $55,65243 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $193 | $45,55340 claims |
| AbbVieSynthroid | $33 | $2,96648 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 352 family medicine providers in Delaware.
Other family medicine in Milford
- David BirchMilford$24K
- David KrasnerWilmington$110K
- Gregory PapaNew Castle$67K
- Sarah MullinsWilmington$36K
- Ashley PanichelliWilmington$27K
- Michelle PapaNewark$23K
- Maryann ConnorWilmington$21K
- Jill MackeyWilmington$20K
- Wayne TuckerBear$20K
- Ian MyersNewark$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.